5 Best Running Shoes for Morton’s Neuroma 2026

If you’re battling the sharp, burning pain of Morton’s neuroma, the ALTRA Men’s Lone Peak 8 delivers a game-changing combination of foot-first design and trail-ready durability. Its zero-drop platform and extra-wide toe box are engineered to eliminate forefoot compression—directly addressing the root cause of neuroma discomfort—while the 25mm cushioned EGO midsole absorbs impact without sacrificing ground feel. This isn’t just a trail shoe; it’s a natural motion sanctuary for runners seeking pain-free miles on rugged terrain or pavement.

Out on the trail, the MaxTrac outsole with TrailClaw lugs bites into loose gravel, wet rocks, and root-strewn paths with unshakable confidence. I tested it on steep descents and technical singletrack, and the high-rebound EGO foam kept my feet responsive and fatigue-free over 10-mile runs. The ripstop mesh upper shrugs off abrasion from brush and scree, stays breathable on warm climbs, and dries quickly after creek crossings. However, in heavy mud, the wide lugs can pack in debris, slightly reducing grip—something to note for wet-weather trail runners.

Compared to structured stability shoes like the New Balance 880 V15, the Lone Peak 8 trades traditional arch support for natural foot alignment, making it ideal for runners prioritizing toe splay and biomechanical health over motion control. It’s the best overall pick for trail lovers with neuroma, offering a rare fusion of protective cushioning, terrain adaptability, and foot-shaped comfort. While not the softest underfoot, its performance-to-comfort ratio outshines most road-to-trail hybrids at this level.

For women with Morton’s neuroma who crave plush, all-day comfort without sacrificing support, the New Balance Fresh Foam X 880 V15 is a cushion-rich revelation. Its Fresh Foam X midsole, now with 3% bio-based content, delivers the softest, most consistent underfoot feel in its class—perfect for runners needing maximum shock absorption to quiet nerve pain. The structured upper hugs the midfoot securely while allowing forefoot expansion, reducing pressure on the inflamed metatarsal area. It’s the go-to choice for long pavement miles where cushioned support trumps agility.

I put the 880 V15 through daily 5K–10K runs on concrete and asphalt, and the plush yet stable ride consistently minimized impact spikes that typically aggravate neuroma symptoms. The midsole doesn’t collapse over time, maintaining its cloud-like resilience even after 100+ miles. While not designed for trails, it handles sidewalks and park paths with quiet confidence, and the breathable engineered mesh keeps feet cool in mild heat. However, the shoe leans heavy compared to more nimble options, making it less ideal for speedwork or tight-turning paths.

Against the ALTRA Lone Peak 8, the 880 V15 wins in cushion depth and arch support, but loses in toe box width and natural foot shaping. It’s best suited for road runners with mild to moderate neuroma pain who prioritize a soft, protective ride over ground feel or foot freedom. While pricier than budget models, its long-term comfort justifies the investment for high-mileage users.

When forefoot pain from Morton’s neuroma demands maximum toe splay and natural movement, the ASITVO Wide Barefoot Shoes make a compelling, budget-friendly case for true foot liberation. The ultra-wide toe box is the standout feature—allowing toes to fan out completely, reducing nerve compression and friction that exacerbate neuroma discomfort. Combined with a zero-drop sole and minimalist knit upper, it promotes a natural gait cycle, strengthens intrinsic foot muscles, and enhances proprioception—key for long-term neuroma management. At under $45, it’s a rare barefoot-style value in a market flooded with premium-priced alternatives.

I tested these on urban jogs, gym sessions, and light trails, and the textured rubber sole provided reliable grip on concrete, tile, and packed dirt. The removable insoles allow users to insert custom orthotics or metatarsal pads—crucial for those needing extra support. The seamless knit upper prevented hot spots during longer walks, and the TPU heel reinforcement added stability often missing in ultra-minimalist designs. However, the cushioning is minimal, so runners used to plush midsoles may find the ride harsh on unforgiving surfaces like concrete after several miles.

Compared to the ALTRA Lone Peak 8, the ASITVO offers a wider forefoot and lower price, but lacks advanced cushioning and trail durability. It’s ideal for budget-conscious users, gym-goers, or walkers with neuroma who want to transition to barefoot-style footwear without breaking the bank. While not built for high-impact running, its foot-shape freedom outperforms many premium models in toe box generosity.

The ASICS GLIDERIDE MAX isn’t just fast—it’s engineered for efficiency, making it a standout for runners with Morton’s neuroma who want energy return without forefoot punishment. The FF BLAST MAX cushioning delivers a buoyant, springy ride that reduces impact while propelling you forward, and when paired with GUIDESOLE technology, it encourages a smooth, rolling gait that minimizes forefoot loading—exactly what neuroma sufferers need to stay active. The HYBRID ASICSGRIP outsole grips wet pavement and dry trails alike, offering surprising versatility for a shoe this responsive.

On tempo runs and long recovery jogs, the GLIDERIDE MAX felt light on its feet, with the 20% bio-based FF BLAST PLUS foam maintaining resilience mile after mile. The engineered mesh upper stayed cool and stretchy, accommodating slight foot swelling without squeezing the forefoot. I ran on mixed surfaces—concrete, asphalt, and crushed gravel—and the shoe handled transitions smoothly, though the rocker profile can feel awkward during sudden stops or lateral movements. It’s not a trail shoe, but it’s surprisingly capable on light off-road paths.

Against the ASICS Gel-Cumulus 27, the GLIDERIDE MAX offers superior energy return and gait efficiency, but at a slightly higher price point and with less plush underfoot cushioning. It’s best for neutral runners with neuroma who want to maintain pace without aggravating nerve pain. While not the widest in the toe box, its forward roll design reduces pressure where it hurts most, making it a smart performance pick.

For runners with Morton’s neuroma who want premium comfort at a surprisingly accessible price, the ASICS Gel-Cumulus 27 is a quiet powerhouse of thoughtful design. The PureGEL technology targets heel and forefoot impact zones with pinpoint cushioning, delivering a softer landing that reduces shock transmission to sensitive nerves. Paired with FF BLAST PLUS foam, it offers a lightweight, bouncy ride that doesn’t collapse under pressure—ideal for daily training on hard surfaces. And with 75% recycled upper material, it’s a shoe that feels good underfoot and for the planet.

I logged multiple 5K runs on city sidewalks, and the FLUIDRIDE outsole ensured a smooth, consistent transition from heel to toe, minimizing jarring forces. The OrthoLite X-30 sockliner added a layer of step-in softness, and the knit heel tab made on/off a breeze. Breathability was solid in mild conditions, though the mesh doesn’t excel in extreme heat. While not as wide as ALTRA or ASITVO models, the forefoot felt roomier than older Cumulus versions—still, wide-footed runners may need to size up.

Stacked against the GLIDERIDE MAX, the Gel-Cumulus 27 trades some energy return for greater cushioning simplicity and affordability, making it the best budget-friendly option in the ASICS lineup. It’s perfect for casual to moderate runners with neuroma who want reliable, eco-conscious performance without overspending. While not the most dynamic, its balanced ride and low cost make it a high-value daily trainer.